Gene · 9833
Papers1,515
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,515
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Precision Oncology Comes of Age: Designing Best-in-Class Small Molecules by Integrating Two Decades of Advances in Chemistry, Target Biology, and Data Science. | Cancer Discov | 2023 | 37712571 | PubTator, text mining | PubMed |
| Identification of molecular subgroups and establishment of risk model based on the response to oxidative stress to predict overall survival of patients with lung adenocarcinoma. | Eur J Med Res | 2023 | 37689745 | PubTator, text mining | PubMed |
| FOXM1, MEK, and CDK4/6: New Targets for Malignant Peripheral Nerve Sheath Tumor Therapy. | Int J Mol Sci | 2023 | 37686402 | PubTator, text mining | PubMed |
| Recapitulation of patient-specific 3D chromatin conformation using machine learning. | Cell Rep Methods | 2023 | 37673071 | PubTator, text mining | PubMed |
| Predicting the target landscape of kinase inhibitors using 3D convolutional neural networks. | PLoS Comput Biol | 2023 | 37669273 | PubTator, text mining | PubMed |
| Delineating intra-tumoral heterogeneity and tumor evolution in breast cancer using precision-based approaches. | Front Genet | 2023 | 37662839 | PubTator, text mining | PubMed |
| MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer. | J Exp Med | 2023 | 37642941 | PubTator, text mining | PubMed |
| Prognostic effect of lncRNA BBOX1-AS1 in malignancies: a meta-analysis. | Front Genet | 2023 | 37636267 | PubTator, text mining | PubMed |
| Multi-omics analyses based on genes associated with oxidative stress and phospholipid metabolism revealed the intrinsic molecular characteristics of pancreatic cancer. | Sci Rep | 2023 | 37604837 | PubTator, text mining | PubMed |
| CEACAM1 as a molecular target in oral cancer. | Aging (Albany NY) | 2023 | 37589542 | PubTator, text mining | PubMed |
| Cancer stem cells in brain tumors: From origin to clinical implications. | MedComm (2020) | 2023 | 37576862 | PubTator, text mining | PubMed |
| Reactive oxygen species mediated apoptotic death of colon cancer cells: therapeutic potential of plant derived alkaloids. | Front Endocrinol (Lausanne) | 2023 | 37560308 | PubTator, text mining | PubMed |
| p53 isoform expression promotes a stemness phenotype and inhibits doxorubicin sensitivity in breast cancer. | Cell Death Dis | 2023 | 37553320 | PubTator, text mining | PubMed |
| Exploration of key ferroptosis-related genes and immune infiltration in Crohn's disease using bioinformatics. | Sci Rep | 2023 | 37550393 | PubTator, text mining | PubMed |
| Integrated multiomics analysis of chromosome 19 miRNA cluster in bladder cancer. | Funct Integr Genomics | 2023 | 37542643 | PubTator, text mining | PubMed |
| Transcriptome profiling analysis of uterus during chicken laying periods. | BMC Genomics | 2023 | 37537566 | PubTator, text mining | PubMed |
| System analysis identifies UBE2C as a novel oncogene target for adrenocortical carcinoma. | PLoS One | 2023 | 37535572 | PubTator, text mining | PubMed |
| Coptisine Inhibits Influenza Virus Replication by Upregulating p21. | Molecules | 2023 | 37513270 | PubTator, text mining | PubMed |
| A Blood-Based Immune Gene Signature with Prognostic Significance in Localized Prostate Cancer. | Cancers (Basel) | 2023 | 37509358 | PubTator, text mining | PubMed |
| The Molecular Pathogenesis of Tumor-Suppressive miR-486-5p and miR-486-3p Target Genes: GINS4 Facilitates Aggressiveness in Lung Adenocarcinoma. | Cells | 2023 | 37508549 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9833/papers?page=10